Saturday, May 30, 2020
- 3:51pm-4:03pm
-
Temporal Trends in Utilization and Outcomes of Sclerotic Donor Kidneys in the United States
Kidney Deceased Donor Selection II • Virtual
- 3:51pm-4:03pm
-
The Banff Classification of Antibody-Mediated Rejection in Kidney Allografts: Comparison of Predictive Performance for Allograft Failure in Previous and Current Editions
Kidney Acute Antibody Mediated Rejection • Virtual
- 3:51pm-4:03pm
-
The Impact of Multi-Organ Transplant Allocation Priority on Wait-Listed Isolated Kidney Transplant Candidates
Kidney Deceased Donor Allocation I • Virtual
- 3:51pm-4:03pm
-
The Liver Outcome Monitoring Registry Donor Risk Index: A New Measure of Deceased Donor Liver Quality
Liver: Recipient Selection • Virtual
- 3:51pm-4:03pm
-
Three Year Post Co-Stimulation Blocking Agent (Belatacept) Switch Outcomes of Kidney Transplant Patients Diagnosed with Post-Transplant Thrombotic Microangiopathy
Novel Immunosuppression: Belatacept • Virtual
- 3:51pm-4:03pm
-
Three-Year Post-Transplant Outcome of Desensitized Mechanical Circulatory Support Patients Awaiting Heart Transplantation
- «Previous Page
- 1
- …
- 192
- 193
- 194
- 195
- 196
- …
- 222
- Next Page»